Doctors test Long-Term safety of liver disease drug duo
NCT ID NCT06755541
Summary
This study aims to check the long-term safety of using two medications, fenofibrate and ursodeoxycholic acid, together in people with Primary Biliary Cholangitis (PBC), a chronic liver disease. It will enroll about 150 adults who have already completed a related earlier study. The main goal is to see how well people tolerate this drug combination over a long period and monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xijing hospital
RECRUITINGXi'an, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.